Shree Ram Proteins Board Meeting: Approves Q1 FY27 Unaudited & FY26 Audited Results; Faces Financial Woes
Shree Ram Proteins Limited's Board met on August 17, 2026, approving unaudited results for Q1 FY27 and audited results for FY26. The company faces significant financial distress, with auditors issuing an adverse opinion due to going concern uncertainties, loan defaults, and auction of assets.
The adverse audit opinion, material uncertainty regarding going concern, and the auction of company assets represent critical issues that will significantly impact the company's operations, financial standing, and investor confidence.
The announcement details significant financial distress, including defaults on loans and statutory dues, auction of company assets, and an adverse audit opinion regarding the company's going concern status. These factors strongly indicate a negative outlook.
Shree Ram Proteins Limited convened its Board of Directors meeting on August 17, 2026, commencing at 2:00 PM and concluding at 2:50 PM at the company's registered office.
During the meeting, the Board considered and approved the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report from the statutory auditors. Additionally, the audited financial results for the quarter and the full year ended March 31, 2026, were also considered, approved, and adopted, accompanied by the audit report.
This intimation is being made available on the company's website at https://www.shreeramproteins.com/ under the investors section. The company's financial statements for the quarter ended June 30, 2026, have been prepared in accordance with Ind AS 34, and the auditors have performed a limited review. However, the auditors' report highlights a material uncertainty related to the company's going concern status due to defaults in loan repayments and statutory dues, and the auction of its plant and machinery. The company is also facing a shortage of working capital and is in the process of raising additional funds. The financial results for the year ended March 31, 2026, also received an adverse opinion from the auditors due to similar concerns regarding going concern, unbooked interest, lack of balance confirmations, and uninspected inventories and fixed assets.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.